Drug Profile
Research programme: anticancer therapeutics - OncoTherapy Science/Nimura Genetic Solutions
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Nimura Genetic Solutions; OncoTherapy Science
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in Japan
- 27 Jul 2005 Preclinical trials in Cancer in Japan (unspecified route)